Literature DB >> 26117465

Comparison of Neoatherosclerosis and Neovascularization Between Patients With and Without Diabetes: An Optical Coherence Tomography Study.

Lei Gao1, Seung-Jung Park2, Yangsoo Jang3, Stephen Lee4, Chong-Jin Kim5, Yoshiyasu Minami1, Daniel Ong1, Tsunenari Soeda6, Rocco Vergallo1, Hang Lee7, Bo Yu8, Shiro Uemura9, Ik-Kyung Jang10.   

Abstract

OBJECTIVES: This study aimed to investigate the characteristics of neoatherosclerosis (NA) in patients with diabetes mellitus (DM) after drug-eluting stent (DES) implantation using optical coherence tomography.
BACKGROUND: NA is an important substrate for stent failure. In vivo NA characteristics in DM patients have not been investigated.
METHODS: A total of 397 patients with 452 DES who underwent follow-up optical coherence tomography examination after DES implantation were enrolled. Characteristics of NA were compared between DM and non-DM patients. Neovascularization was defined as signal-poor holes or tubular structures with a diameter of 50 to 300 μm.
RESULTS: A total of 123 DES with NA lesions in 115 patients were identified. The incidence of NA was similar between DM and non-DM patients (29.6% vs. 28.6%; p = 0.825). Compared with the non-DM group, neovascularization was more frequently observed in the DM group (55.1% vs. 32.4%; p = 0.012). The multivariate logistic model demonstrated that DM (odds ratio: 3.00; 95% confidence interval: 1.31 to 6.81; p = 0.009) and follow-up duration (odds ratio: 1.03; 95% confidence interval: 1.02 to 1.05; p < 0.001) were the independent predictors for neovascularization in NA lesions. DM patients with glycated hemoglobin ≥7.0% had a higher prevalence of thin-cap fibroatheroma compared with those with glycated hemoglobin <7.0% (40.0% vs. 8.3%; p = 0.01).
CONCLUSIONS: The incidence of NA was similar between patients with and without DM. Neovascularization in NA lesions was more frequent in those with DM. Poorly controlled DM patients had a higher incidence of thin-cap fibroatheroma, compared with those with well-controlled DM.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atherosclerosis; diabetes mellitus; drug-eluting stent

Mesh:

Substances:

Year:  2015        PMID: 26117465     DOI: 10.1016/j.jcin.2015.02.020

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  5 in total

1.  Five factors and three characteristics of coronary in-stent restenosis.

Authors:  Nobuaki Suzuki
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

2.  Biosafety and efficacy evaluation of a biodegradable magnesium-based drug-eluting stent in porcine coronary artery.

Authors:  Jinzhou Zhu; Xiyuan Zhang; Jialin Niu; Yongjuan Shi; Zhengbin Zhu; Daopeng Dai; Chenxin Chen; Jia Pei; Guangyin Yuan; Ruiyan Zhang
Journal:  Sci Rep       Date:  2021-04-01       Impact factor: 4.379

Review 3.  Pathogenesis and Clinical Significance of In-Stent Restenosis in Patients with Diabetes.

Authors:  Grzegorz K Jakubiak; Natalia Pawlas; Grzegorz Cieślar; Agata Stanek
Journal:  Int J Environ Res Public Health       Date:  2021-11-15       Impact factor: 3.390

4.  Comparison of symptomatic vertebrobasilar plaques between patients with and without Diabetes Mellitus using computed tomographic angiography and vessel wall magnetic resonance imaging.

Authors:  Huan Yang; Bo Liu; Qingqing Yin; Shuai Zhang; Yelong Shen; Congshan Ji; Haipeng Wang; Yin Dong; Liangjie Lin; Ximing Wang
Journal:  Diab Vasc Dis Res       Date:  2022 Jan-Feb       Impact factor: 3.291

5.  Efficacy of Zotarolimus-Eluting Stents in Treating Diabetic Coronary Lesions: An Optical Coherence Tomography Study.

Authors:  Zhengbin Zhu; Jinzhou Zhu; Run Du; Haotian Zhang; Jinwei Ni; Weiwei Quan; Jian Hu; Fenghua Ding; Zhenkun Yang; Ruiyan Zhang
Journal:  Adv Ther       Date:  2020-03-07       Impact factor: 3.845

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.